Literature DB >> 17547846

What's new in blistering disorders?

Paru Chaudhari1, M Peter Marinkovich.   

Abstract

From the characterization of new animal models for the study of disease pathogenesis, to the demonstration of new therapeutic modalities, many developments have revolutionized the field of autoimmune bullous diseases in the past several years. This review highlights many of the significant advances that have taken place in the diagnosis, pathogenesis, and treatment options for pemphigus, pemphigoid, epidermolysis bullosa acquisita, and immunoglobulin (Ig) A-mediated bullous disorders.

Entities:  

Mesh：

Year:  2007        PMID： 17547846     DOI： 10.1007/s11882-007-0038-7

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN： 1529-7322            Impact factor:   4.806


  68 in total

1.  Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.

Authors:  D Zillikens; K Herzele; M Georgi; E Schmidt; I Chimanovitch; H Schumann; J M Mascaro; L A Diaz; L Bruckner-Tuderman; E B Bröcker; G J Giudice
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

2.  Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment.

Authors:  A R Ahmed
Journal:  J Am Acad Dermatol       Date:  2001-11       Impact factor: 11.527

Review 3.  Structure and biological activity of the extracellular matrix.

Authors:  M Aumailley; B Gayraud
Journal:  J Mol Med (Berl)       Date:  1998-03       Impact factor: 4.599

4.  Pemphigus therapy with oral prednisolone regimens. A 5-year study.

Authors:  K V Ratnam; K L Phay; C K Tan
Journal:  Int J Dermatol       Date:  1990-06       Impact factor: 2.736

5.  The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris.

Authors:  M S Turner; D Sutton; D N Sauder
Journal:  J Am Acad Dermatol       Date:  2000-12       Impact factor: 11.527

Review 6.  The molecular genetics of basement membrane diseases.

Authors:  M P Marinkovich
Journal:  Arch Dermatol       Date:  1993-12

Review 7.  An array of possibilities for the study of autoimmunity.

Authors:  C Garrison Fathman; Luis Soares; Steven M Chan; Paul J Utz
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

8.  IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris.

Authors:  Jean-Claude Bystryn; Diane Jiao
Journal:  Autoimmunity       Date:  2006-11       Impact factor: 2.815

9.  Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.

Authors:  M G Mahoney; Z Wang; K Rothenberger; P J Koch; M Amagai; J R Stanley
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

10.  Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa.

Authors:  J C Lapiere; D T Woodley; M G Parente; T Iwasaki; K C Wynn; A M Christiano; J Uitto
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808
View more
  2 in total

Review 1.  Basement membranes in skin: unique matrix structures with diverse functions?

Authors:  Dirk Breitkreutz; Nicolae Mirancea; Roswitha Nischt
Journal:  Histochem Cell Biol       Date:  2009-03-31       Impact factor: 4.304

Review 2.  Skin basement membrane: the foundation of epidermal integrity--BM functions and diverse roles of bridging molecules nidogen and perlecan.

Authors:  Dirk Breitkreutz; Isabell Koxholt; Kathrin Thiemann; Roswitha Nischt
Journal:  Biomed Res Int       Date:  2013-03-21       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.